Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D02011 (
FAD
)
5,530
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. The roles of the three protein components of soluble methane mono-oxygenase were investigated by the use of rapid-reaction techniques. The transfer of electrons through the enzyme complex from NADH to methane/O2 was also investigated. 2. Electron transfer from
protein C
, the reductase component, to protein A, the hydroxylase component, was demonstrated.
Protein C
was shown to undergo a three-electron--one-electron catalytic cycle. The interaction of
protein C
with NADH was investigated. Reduction of
protein C
was shown to be rapid, and a charge-transfer interaction between reduced
FAD
and NAD+ was observed; this intermediate was also found in static titration experiments. Thus the binding of NADH, the reduction of
protein C
and the intramolecular transfer of electrons through
protein C
were shown to be much more rapid than the turnover rate of methane mono-oxygenase. 3. The rate of transfer of electrons from
protein C
to protein A was shown to be lower than the reduction of
protein C
but higher than the turnover rate of methane mono-oxygenase. Association of the proteins was not rate-limiting. The amount of protein A present in the system had a small effect on the rate of reduction of
protein C
, indicating some co-operativity between the two proteins. 4. Protein B was shown to prevent electron transfer between
protein C
and protein A in the absence of methane. On addition of saturating concentrations of methane electron transfer was restored. With saturating concentrations of methane and O2 the observed rate constant for the conversion of methane into methanol was 0.26 s-1 at 18 degrees C. 5. By the use of [2H4]methane it was demonstrated that C-H-bond breakage is likely to be the rate-limiting step in the conversion of methane into methanol.
...
PMID:A stopped-flow kinetic study of soluble methane mono-oxygenase from Methylococcus capsulatus (Bath). 249 29
Copper(I), copper(II) and silver ions have been shown to be potent inhibitors of purified soluble methane monooxygenase (MMO) of Methylococcus capsulatus (Bath). A weaker inhibition has been observed with zinc and cadmium ions. Proteins A and B of soluble MMO are unaffected by copper but
protein C
is rapidly and irreversibly inhibited. The site of copper inhibition has been shown to be primarily at the iron-sulphur centre of
protein C
with a secondary effect at the
FAD
centre when the copper(II):
protein C
ratio is high. Copper appears to bring about the inhibition of soluble MMO by interacting with
protein C
to disrupt the protein structure causing, firstly, the loss of the iron-sulphur centre, preventing the transfer of electrons from
protein C
to protein A, and secondly, the loss of
FAD
preventing the protein from accepting electrons from NADH. Inhibition and spectral data are provided to support this thesis. The inactivation of
protein C
is associated with the tight binding of four Cu atoms to each
protein C
molecule. These data extend our knowledge of how copper, which is known to have a key role in the cellular location of MMO, interacts with and rapidly and irreversibly inactivates the soluble form of this enzyme.
...
PMID:Copper ions as inhibitors of protein C of soluble methane monooxygenase of Methylococcus capsulatus (Bath). 393 77
We examined if sevoflurane given before cold ischemia of intact hearts (anesthetic preconditioning,
APC
) affords additional protection by further improving mitochondrial energy balance and if this is abolished by a mitochondrial KATP blocker. NADH and
FAD
fluorescence was measured within the left ventricular wall of 5 groups of isolated guinea pig hearts: (1) hypothermia alone; (2) hypothermia+ischemia; (3)
APC
(4.1% sevoflurane)+cold ischemia; (4) 5-HD+cold ischemia, and (5) APC+5-HD+cold ischemia. Hearts were exposed to sevoflurane for 15 minutes followed by 15 minutes of washout at 37 degrees C before cooling, 2 hours of 27 degrees C ischemia, and 2 hours of 37 degrees C reperfusion. The KATP channel inhibitor 5-HD was perfused before and after sevoflurane. Ischemia caused a rapid increase in NADH and a decrease in
FAD
that waned over 2 hours. Warm reperfusion led to a decrease in NADH and an increase in
FAD
.
APC
attenuated the changes in NADH and
FAD
and further improved postischemic function and reduced infarct size. 5-HD blocked the cardioprotective effects of
APC
but not
APC
-induced alterations of NADH and
FAD
. Thus,
APC
improves redox balance and has additive cardioprotective effects with mild hypothermic ischemia. 5-HD blocks
APC
-induced cardioprotective effects but not improvements in mitochondrial bioenergetics. This suggests that mediation of protection by KATP channel opening during cold ischemia and reperfusion is downstream from the
APC
-induced improvement in redox state or that these changes in redox state are not attenuated by KATP channel antagonism.
...
PMID:Improved mitochondrial bioenergetics by anesthetic preconditioning during and after 2 hours of 27 degrees C ischemia in isolated hearts. 1611 32